Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

0.1620
-0.1941-54.51%
Post-market: 0.27000.1080+66.67%19:59 EDT
Volume:3.85M
Turnover:1.03M
Market Cap:2.64M
PE:-0.06
High:0.3490
Open:0.3490
Low:0.1620
Close:0.3561
52wk High:5.20
52wk Low:0.1620
Shares:16.29M
Float Shares:12.55M
Volume Ratio:2.75
T/O Rate:30.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8935
EPS(LYR):-4.8401
ROE:-136.16%
ROA:-73.78%
PB:0.17
PE(LYR):-0.03

Loading ...

Mangoceuticals Inc - Intends to Vigorously Pursue Its Claims and Defend Against Counterclaims Through Litigation Process

THOMSON REUTERS
·
Mar 18

Mangoceuticals Inc - Clarity Has Denied Co's Allegations and Has Asserted Counterclaims Related to Alleged Unpaid Invoices

THOMSON REUTERS
·
Mar 18

Mangoceuticals sues Clarity Ventures for more than USD 73 million

Reuters
·
Mar 18

Mangoceuticals announces patent filing for MGX-0024

TIPRANKS
·
Mar 07

Mangoceuticals Reports Zero Respiratory-Related Mortality in 29,000-Bird MGX-0024 Trials

Reuters
·
Mar 07

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

GlobeNewswire
·
Mar 07

Mangoceuticals Says MGX-0024 Cuts H5N1 Deaths and Eliminates Respiratory Mortality in Poultry Trials

Reuters
·
Feb 24

Mangoceuticals Inc - Mortality Reduced by up to 60% in Pre-Treatment Group

THOMSON REUTERS
·
Feb 24

Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

GlobeNewswire
·
Feb 24

Mangoceuticals Shares Rise 81% on Strong Sales of Injectable Testosterone Therapy

THOMSON REUTERS
·
Feb 20

Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today

TIPRANKS
·
Feb 20

BUZZ-Mangoceuticals surges on strong sales of injectable testosterone therapy

Reuters
·
Feb 20

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

GlobeNewswire
·
Feb 20

Mangoceuticals files to sell 2.64M shares of common stock for holders

TIPRANKS
·
Jan 14

Top Midday Decliners

MT Newswires Live
·
Dec 20, 2025

Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results

Benzinga
·
Dec 20, 2025

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

GlobeNewswire
·
Dec 19, 2025

BRIEF-Mangoceuticals Announces Partnership With The Cube Group

Reuters
·
Dec 19, 2025

Mangoceuticals Inc. Plans Up to $100 Million Solana-Focused Digital Asset Treasury Strategy with Cube Group, Targeting Yield Generation and Diversified Crypto Expansion

Reuters
·
Dec 19, 2025

Mangoceuticals, Inc. Announces Partnership With the Cube Group to Launch up to $100 Million Solana-Focused Digital Asset Treasury (Dat) Strategy

THOMSON REUTERS
·
Dec 19, 2025